Stocks and Investing
Stocks and Investing
Thu, June 29, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, June 28, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Liana Moussatos Reiterated (VRNA) at Buy and Held Target at $30 on, Jun 28th, 2023
Liana Moussatos of Wedbush, Reiterated "Verona Pharma plc" (VRNA) at Buy and Held Target at $30 on, Jun 28th, 2023.
Liana has made no other calls on VRNA in the last 4 months.
There are 4 other peers that have a rating on VRNA. Out of the 4 peers that are also analyzing VRNA, 0 agree with Liana's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Liana
- Joon Lee of "Truist Securities" Reiterated at Strong Buy and Held Target at $32 on, Tuesday, June 27th, 2023
- Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $32 on, Tuesday, June 27th, 2023
- Edward Nash of "Canaccord Genuity" Maintained at Sell with Increased Target to $33 on, Wednesday, May 10th, 2023
- Thomas Shrader of "BTIG" Maintained at Strong Buy with Increased Target to $31 on, Monday, March 20th, 2023
Contributing Sources